z-logo
Premium
ACCUMULATION AND DISAPPEARANCE OF NORADRENALINE AND ITS MAJOR METABOLITES SYNTHESIZED FROM INTRAVENTRICULARLY INJECTED [ 3 H]DOPAMINE IN THE RAT BRAIN
Author(s) -
Braestrup C.,
Nielsen M.,
ScheelKrüger J.
Publication year - 1974
Publication title -
journal of neurochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.75
H-Index - 229
eISSN - 1471-4159
pISSN - 0022-3042
DOI - 10.1111/j.1471-4159.1974.tb06061.x
Subject(s) - normetanephrine , chemistry , metabolite , dopamine , mandelic acid , conjugated system , medicine , endocrinology , chromatography , biochemistry , urine , organic chemistry , polymer
— A new combined ion‐exchange and thin‐layer‐chromatographic procedure is described which separates and measures quantitatively, after intraventricular injection of [ 3 H]dopamine (DA), the rat brain content of labelled noradrenaline (NA) and the following labelled noradrenaline metabolites: free 3‐methoxy‐4‐hydroxyphenylethyleneglycol (MOPEG), conjugated MOPEG, free plus conjugated dihydroxyphenylethyleneglycol (DOPEG), vanillic mandelic acid (VMA) and normetanephrine (NM). Labelled dopamine and its metabolites were also measured. The time‐course study performed from 5 min to 24 h after [ 3 H]DA showed that MOPEG and DOPEG, mainly as conjugates, are major NA metabolites whereas VMA is a very insignificant NA metabolite in the rat brain. A very rapid initial increase of [ 3 H]NM, free MOPEG and conjugated MOPEG was found during the time interval where the [ 3 H]NA biosynthesis is very high (0–15 min). This combined with the finding that these metabolites stabilize at lower levels during the [ 3 H]NA ‘storage phase’ (9–24 h) provides a strong indication that newly synthesized NA preferentially is metabolized. Our measurements of endogenous NA, free MOPEG and conjugated MOPEG provide additional support. The injections of various decreasing doses of [ 3 H]DA (3·08–0·0010 μg) showed that the proportions of total [ 3 H]MOPEG and total [ 3 H]DOPEG to [ 3 H]NA were constant after all [ 3 H]DA doses investigated. This finding indicates that the [ 3 H]NA synthesized in situ behaves as a tracer, even after injections of non‐tracer doses of [ 3 H]DA. The results seem thus to indicate that the present technique provides a powerful tool for the investigations on central noradrenaline metabolism.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom